1. Mutations in amyloid precursor protein affect its interactions with presenilin/γ-secretase
- Author
-
Christina M. Lill, Anne V. Thomas, Bradley T. Hyman, Oksana Berezovska, Lauren Herl, Phill Jones, Mary Banks, Amy Deng, and Robert Spoelgen
- Subjects
Protein Conformation ,Mutant ,CHO Cells ,Article ,Presenilin ,Amyloid beta-Protein Precursor ,Cellular and Molecular Neuroscience ,Cricetulus ,Protein structure ,Alzheimer Disease ,Cricetinae ,mental disorders ,Fluorescence Resonance Energy Transfer ,medicine ,Amyloid precursor protein ,Animals ,Humans ,Molecular Biology ,Secretory pathway ,biology ,Presenilins ,Cell Biology ,medicine.disease ,nervous system diseases ,Transport protein ,Cell biology ,Protein Transport ,nervous system ,Biochemistry ,Mutation ,biology.protein ,Amyloid Precursor Protein Secretases ,Alzheimer's disease ,Amyloid precursor protein secretase - Abstract
Alzheimer's disease is characterized by accumulation of toxic beta-amyloid (Abeta) in the brain and neuronal death. Several mutations in presenilin (PS1) and beta-amyloid precursor protein (APP) associate with an increased Abeta(42/40) ratio. Abeta(42), a highly fibrillogenic species, is believed to drive Abeta aggregation. Factors shifting gamma-secretase cleavage of APP to produce Abeta(42) are unclear. We investigate the molecular mechanism underlying altered Abeta(42/40) ratios associated with APP mutations at codon 716 and 717. Using FRET-based fluorescence lifetime imaging to monitor APP-PS1 interactions, we show that I716F and V717I APP mutations increase the proportion of interacting molecules earlier in the secretory pathway, resulting in an increase in Abeta generation. A PS1 conformation assay reveals that, in the presence of mutant APP, PS1 adopts a conformation reminiscent of FAD-associated PS1 mutations, thus influencing APP binding to PS1/gamma-secretase. Mutant APP affects both intracellular location and efficiency of APP-PS1 interactions, thereby changing the Abeta(42/40) ratio.
- Published
- 2009